Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Clinical trial NCT00039780 · COMPLETED

Trial details

NCT number: NCT00039780
Sponsor: BioNumerik Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms Breast Diseases Metastases, Neoplasm

Start date: 2001-09-01
Primary completion: 2006-10-01
Enrollment: 764

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.